FISH OIL

FISH OIL was reported 75559 times

FISH OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP VEIN THROMBOSIS POSTOPERATIVE 113 0.3029
1 FACET JOINT SYNDROME 133 0.1727
2 PERIPHERAL VENOUS DISEASE 143 0.0830
3 DUODENAL ULCER PERFORATION 264 0.0791
4 SWOLLEN JOINT COUNT INCREASED 68 0.0724
5 RHEUMATIC FEVER 89 0.0673
6 MUSCLE INJURY 304 0.0668
7 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 47 0.0646
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 223 0.0600
9 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 188 0.0536
10 FOLLICULITIS 285 0.0536
11 HELICOBACTER INFECTION 273 0.0471
12 RHEUMATOID FACTOR POSITIVE 157 0.0467
13 C-REACTIVE PROTEIN ABNORMAL 150 0.0395
14 LIP DRY 187 0.0350
15 HYPERPARATHYROIDISM SECONDARY 79 0.0341
16 PEMPHIGUS 261 0.0337
17 FLUSHING 2941 0.0336
18 HAND DEFORMITY 274 0.0316
19 MUSCLE SPASTICITY 328 0.0304
20 HIGH DENSITY LIPOPROTEIN DECREASED 86 0.0303
21 NEPHROGENIC ANAEMIA 127 0.0291
22 PERICARDITIS 287 0.0280
23 AUTOIMMUNE DISORDER 162 0.0280
24 REBOUND ACID HYPERSECRETION 83 0.0278
25 BURSITIS 220 0.0270
26 EAR PAIN 409 0.0265
27 PRE-EXISTING CONDITION IMPROVED 152 0.0263
28 IRRITABLE BOWEL SYNDROME 400 0.0262
29 NIGHT SWEATS 634 0.0260
30 ESSENTIAL HYPERTENSION 53 0.0250
31 GLOSSODYNIA 411 0.0249
32 JOINT RANGE OF MOTION DECREASED 213 0.0230
33 SYNOVITIS 291 0.0225
34 BLOOD TESTOSTERONE DECREASED 135 0.0220
35 HAEMORRHAGIC ANAEMIA 92 0.0209
36 BLOOD CHOLESTEROL INCREASED 765 0.0208
37 FEELING HOT 1037 0.0205
38 TENDON PAIN 123 0.0198
39 EXOSTOSIS 139 0.0195
40 UPPER-AIRWAY COUGH SYNDROME 117 0.0192
41 FIBROMYALGIA 338 0.0187
42 BODY TEMPERATURE INCREASED 318 0.0186
43 TRIGGER FINGER 57 0.0185
44 WALKING AID USER 91 0.0184
45 CONTRAINDICATED PRODUCT ADMINISTERED 402 0.0183
46 IMPAIRED HEALING 462 0.0183
47 WOUND 358 0.0181
48 LOW DENSITY LIPOPROTEIN INCREASED 105 0.0181
49 OBESITY 213 0.0180
50 GLUCOSE TOLERANCE IMPAIRED 81 0.0179
51 SINUSITIS 1452 0.0179
52 MENISCUS INJURY 88 0.0178
53 OSTEOARTHRITIS 591 0.0178
54 SKIN ABRASION 60 0.0178
55 BLOOD CHOLESTEROL ABNORMAL 64 0.0176
56 VITAMIN D DECREASED 124 0.0176
57 BODY HEIGHT DECREASED 170 0.0175
58 SLEEP APNOEA SYNDROME 283 0.0175
59 PROSTATOMEGALY 55 0.0173
60 PLANTAR FASCIITIS 45 0.0168
61 LOWER RESPIRATORY TRACT INFECTION 542 0.0168
62 THYROID FUNCTION TEST ABNORMAL 62 0.0168
63 INTERVERTEBRAL DISC DEGENERATION 135 0.0167
64 ROSACEA 58 0.0165
65 SCIATICA 185 0.0165
66 VITAMIN D DEFICIENCY 126 0.0164
67 MUSCULOSKELETAL PAIN 778 0.0164
68 PARANASAL SINUS HYPERSECRETION 54 0.0163
69 URINE ABNORMALITY 55 0.0162
70 LIGAMENT RUPTURE 58 0.0161
71 VITREOUS FLOATERS 114 0.0159
72 SYNOVIAL CYST 61 0.0158
73 SPINAL COLUMN STENOSIS 75 0.0158
74 ROTATOR CUFF SYNDROME 169 0.0158
75 BLOOD MAGNESIUM DECREASED 104 0.0157
76 BLOOD TRIGLYCERIDES INCREASED 234 0.0157
77 DIZZINESS POSTURAL 107 0.0156
78 ONYCHOMYCOSIS 47 0.0155
79 MIDDLE INSOMNIA 220 0.0154
80 BLOOD CALCIUM INCREASED 110 0.0153
81 DIVERTICULUM 102 0.0153
82 CONTUSION 1165 0.0153
83 DRY EYE 473 0.0153
84 DECREASED INTEREST 77 0.0152
85 SINUS DISORDER 240 0.0152
86 SQUAMOUS CELL CARCINOMA OF SKIN 68 0.0151
87 INCREASED TENDENCY TO BRUISE 119 0.0151
88 SPINAL FUSION SURGERY 44 0.0151
89 GASTROOESOPHAGEAL REFLUX DISEASE 950 0.0151
90 CORONARY ARTERY OCCLUSION 181 0.0150
91 EPIGASTRIC DISCOMFORT 48 0.0149
92 MACULAR DEGENERATION 138 0.0149
93 RESPIRATORY DISORDER 353 0.0147
94 CARPAL TUNNEL SYNDROME 166 0.0147
95 SYSTEMIC LUPUS ERYTHEMATOSUS 348 0.0147
96 FACE INJURY 43 0.0147
97 SINUS HEADACHE 76 0.0147
98 DIABETIC NEUROPATHY 64 0.0147
99 SKIN ATROPHY 65 0.0146
100 PSORIATIC ARTHROPATHY 381 0.0145
101 SPINAL OSTEOARTHRITIS 106 0.0145
102 SINUS CONGESTION 157 0.0144
103 INITIAL INSOMNIA 109 0.0144
104 MUSCLE STRAIN 101 0.0143
105 ARTHROPATHY 635 0.0143
106 KNEE ARTHROPLASTY 208 0.0142
107 JOINT SWELLING 1310 0.0142
108 SNORING 43 0.0142
109 PERIPHERAL SWELLING 1639 0.0142
110 PARAESTHESIA 1855 0.0141
111 HAIR COLOUR CHANGES 158 0.0141
112 EYE INFECTION 115 0.0140
113 TENDERNESS 121 0.0140
114 MULTIPLE ALLERGIES 81 0.0140
115 LOWER LIMB FRACTURE 195 0.0139
116 GRIP STRENGTH DECREASED 78 0.0139
117 STOMATITIS 649 0.0138
118 MICTURITION URGENCY 124 0.0138
119 HIP ARTHROPLASTY 150 0.0138
120 SEASONAL ALLERGY 133 0.0138
121 DRY MOUTH 875 0.0138
122 TEMPERATURE INTOLERANCE 106 0.0138
123 BASAL CELL CARCINOMA 170 0.0137
124 GROIN PAIN 100 0.0137
125 CARDIAC FLUTTER 71 0.0137
126 GAIT INABILITY 288 0.0136
127 ORAL PAIN 252 0.0136
128 BONE DENSITY ABNORMAL 45 0.0136
129 HYPERLIPIDAEMIA 140 0.0136
130 PERONEAL NERVE PALSY 64 0.0135
131 ONYCHOCLASIS 72 0.0135
132 SKIN PAPILLOMA 43 0.0135
133 HAIR TEXTURE ABNORMAL 164 0.0135
134 CHRONIC KIDNEY DISEASE 926 0.0135
135 OSTEOPENIA 172 0.0134
136 TONGUE DISCOLOURATION 53 0.0134
137 LEFT VENTRICULAR HYPERTROPHY 48 0.0134
138 GINGIVAL DISORDER 44 0.0133
139 URINE ODOUR ABNORMAL 65 0.0132
140 BLISTER 567 0.0132
141 GENERALISED ERYTHEMA 75 0.0131
142 PROSTATIC SPECIFIC ANTIGEN INCREASED 146 0.0131
143 GASTROINTESTINAL SOUNDS ABNORMAL 46 0.0131
144 EAR DISCOMFORT 104 0.0131
145 ERYTHEMA OF EYELID 52 0.0131
146 INCREASED UPPER AIRWAY SECRETION 61 0.0131
147 MELANOCYTIC NAEVUS 45 0.0131
148 NOCTURIA 119 0.0130
149 HEPATIC ENZYME INCREASED 670 0.0130
150 BREAST MASS 71 0.0130
151 MUSCULOSKELETAL CHEST PAIN 161 0.0130
152 GOUT 186 0.0130
153 ABDOMINAL HERNIA 49 0.0130
154 POOR QUALITY SLEEP 212 0.0130
155 BALANCE DISORDER 919 0.0129
156 TENDONITIS 168 0.0128
157 LACERATION 121 0.0128
158 AGEUSIA 260 0.0128
159 LOWER GASTROINTESTINAL HAEMORRHAGE 84 0.0128
160 INTERVERTEBRAL DISC PROTRUSION 235 0.0128
161 FULL BLOOD COUNT DECREASED 191 0.0127
162 HAEMORRHOIDAL HAEMORRHAGE 53 0.0127
163 FLATULENCE 563 0.0126
164 INTERNATIONAL NORMALISED RATIO DECREASED 49 0.0126
165 HEART RATE ABNORMAL 53 0.0126
166 TENDON DISORDER 68 0.0126
167 NERVE COMPRESSION 92 0.0126
168 GASTROENTERITIS VIRAL 171 0.0126
169 NEURALGIA 234 0.0125
170 BLOOD IRON DECREASED 106 0.0125
171 SCAB 110 0.0125
172 MUSCULOSKELETAL STIFFNESS 872 0.0124
173 PRURITUS 3312 0.0124
174 LIGAMENT SPRAIN 94 0.0124
175 THERAPEUTIC PRODUCT EFFECT DECREASED 370 0.0124
176 WOUND INFECTION 88 0.0124
177 HEART RATE IRREGULAR 242 0.0123
178 NAIL DISORDER 75 0.0123
179 HAIR GROWTH ABNORMAL 69 0.0123
180 TENDON RUPTURE 128 0.0122
181 EXERCISE TOLERANCE DECREASED 55 0.0122
182 PRODUCT SUBSTITUTION ISSUE 585 0.0122
183 MUSCLE TIGHTNESS 163 0.0122
184 MUSCULAR WEAKNESS 1101 0.0121
185 TONGUE DISORDER 77 0.0121
186 PRURITUS GENERALISED 262 0.0121
187 SENSORY DISTURBANCE 169 0.0121
188 DYSPEPSIA 932 0.0121
189 BLADDER DISORDER 100 0.0121
190 TASTE DISORDER 135 0.0121
191 END STAGE RENAL DISEASE 199 0.0121
192 BURNING SENSATION 697 0.0121
193 FOREIGN BODY 47 0.0120
194 RED BLOOD CELL COUNT DECREASED 272 0.0120
195 INJECTION SITE PAPULE 45 0.0120
196 PNEUMONIA ASPIRATION 234 0.0120
197 BRONCHITIS 740 0.0120
198 NASAL DRYNESS 59 0.0119
199 BACK PAIN 2242 0.0119
200 CYST 118 0.0119
201 MUSCULOSKELETAL DISCOMFORT 162 0.0119
202 POLLAKIURIA 396 0.0118
203 INFUSION SITE SWELLING 46 0.0118
204 SKIN LACERATION 89 0.0118
205 MUSCLE SPASMS 1762 0.0118
206 TYPE 2 DIABETES MELLITUS 317 0.0118
207 CONCUSSION 71 0.0118
208 DISCOMFORT 510 0.0118
209 MUSCLE DISORDER 82 0.0117
210 LOCAL SWELLING 205 0.0117
211 ABDOMINAL TENDERNESS 48 0.0117
212 CATARACT OPERATION 55 0.0117
213 EYE PAIN 461 0.0116
214 LIVER INJURY 174 0.0116
215 ARTERIOSCLEROSIS CORONARY ARTERY 62 0.0116
216 BACK DISORDER 153 0.0116
217 RASH PRURITIC 477 0.0116
218 STRESS FRACTURE 55 0.0116
219 HYPERKERATOSIS 51 0.0115
220 WRIST FRACTURE 112 0.0115
221 HUNGER 97 0.0115
222 NERVE INJURY 107 0.0115
223 PELVIC FRACTURE 71 0.0115
224 NECK PAIN 515 0.0115
225 ABDOMINAL DISCOMFORT 1487 0.0115
226 TOOTH INFECTION 119 0.0114
227 HOT FLUSH 635 0.0114
228 FOOT DEFORMITY 100 0.0114
229 LARYNGITIS 94 0.0114
230 HIATUS HERNIA 125 0.0114
231 ARTHRITIS 707 0.0114
232 WEIGHT FLUCTUATION 87 0.0114
233 INSOMNIA 2488 0.0114
234 VIRAL UPPER RESPIRATORY TRACT INFECTION 48 0.0113
235 FOOD POISONING 43 0.0113
236 JOINT EFFUSION 65 0.0113
237 CATARACT 502 0.0112
238 LIMB DISCOMFORT 275 0.0112
239 ABNORMAL FAECES 71 0.0112
240 LACRIMATION INCREASED 241 0.0111
241 CONSTIPATION 1803 0.0111
242 FAECES DISCOLOURED 198 0.0111
243 PRODUCT FORMULATION ISSUE 60 0.0111
244 RENAL CYST 74 0.0111
245 JOINT STIFFNESS 234 0.0111
246 THERAPEUTIC RESPONSE UNEXPECTED 415 0.0111
247 RESTLESS LEGS SYNDROME 166 0.0111
248 HYPERSOMNIA 251 0.0111
249 ERUCTATION 144 0.0111
250 MYALGIA 1517 0.0111
251 UPPER RESPIRATORY TRACT INFECTION 398 0.0111
252 NASOPHARYNGITIS 1548 0.0110
253 NEUROPATHY PERIPHERAL 778 0.0110
254 EAR DISORDER 41 0.0110
255 VENTRICULAR EXTRASYSTOLES 96 0.0110
256 ORAL MUCOSAL BLISTERING 57 0.0110
257 SWELLING 799 0.0109
258 FEELING JITTERY 178 0.0109
259 CYSTITIS 292 0.0109
260 SKIN HAEMORRHAGE 101 0.0109
261 PRESCRIBED OVERDOSE 166 0.0109
262 FEELING DRUNK 69 0.0109
263 BLOOD URINE PRESENT 173 0.0109
264 SLEEP DISORDER 563 0.0109
265 HYPERAESTHESIA 77 0.0108
266 HAIR DISORDER 85 0.0108
267 ULCER HAEMORRHAGE 59 0.0108
268 POST-TRAUMATIC STRESS DISORDER 55 0.0108
269 FOOD ALLERGY 50 0.0108
270 LYMPHOEDEMA 57 0.0108
271 PAIN IN EXTREMITY 2636 0.0108
272 ACTIVITIES OF DAILY LIVING IMPAIRED 213 0.0107
273 NEPHROLITHIASIS 375 0.0107
274 HYPOAESTHESIA 1304 0.0107
275 BACK INJURY 84 0.0107
276 OCULAR DISCOMFORT 73 0.0107
277 GINGIVAL PAIN 68 0.0107
278 ALOPECIA 1722 0.0107
279 OROPHARYNGEAL PAIN 772 0.0106
280 BONE DISORDER 171 0.0106
281 RHINORRHOEA 517 0.0106
282 FACIAL PAIN 72 0.0106
283 ABDOMINAL PAIN UPPER 1704 0.0106
284 ARTHRALGIA 3330 0.0106
285 FATIGUE 6363 0.0105
286 LIMB INJURY 216 0.0105
287 ASTHENIA 3150 0.0105
288 GAIT DISTURBANCE 1643 0.0105
289 SNEEZING 175 0.0105
290 DRY THROAT 85 0.0105
291 TINNITUS 385 0.0105
292 PROCTALGIA 54 0.0105
293 BLOOD URIC ACID INCREASED 46 0.0105
294 IMPAIRED DRIVING ABILITY 99 0.0105
295 DYSPHONIA 481 0.0104
296 PRESCRIBED UNDERDOSE 158 0.0104
297 NODULE 107 0.0104
298 DYSGEUSIA 661 0.0104
299 HAND FRACTURE 59 0.0104
300 VARICOSE VEIN 44 0.0104
301 ROAD TRAFFIC ACCIDENT 348 0.0104
302 THERAPY CESSATION 399 0.0104
303 EYE HAEMORRHAGE 116 0.0104
304 ATRIAL FLUTTER 70 0.0104
305 BLOOD POTASSIUM DECREASED 253 0.0104
306 HYPERCHOLESTEROLAEMIA 68 0.0104
307 FAECES SOFT 47 0.0104
308 TOOTHACHE 150 0.0103
309 LARGE INTESTINE POLYP 58 0.0103
310 SCOLIOSIS 53 0.0103
311 MADAROSIS 112 0.0103
312 ILL-DEFINED DISORDER 350 0.0103
313 RIB FRACTURE 170 0.0103
314 ANKLE FRACTURE 130 0.0103
315 FORMICATION 62 0.0102
316 POLYP 54 0.0102
317 BLOOD POTASSIUM INCREASED 135 0.0102
318 NASAL CONGESTION 440 0.0101
319 PHOTOPSIA 52 0.0101
320 PHOTOPHOBIA 143 0.0101
321 TOOTH DISORDER 188 0.0101
322 HEAD DISCOMFORT 133 0.0101
323 LOCALISED INFECTION 194 0.0101
324 DYSGRAPHIA 55 0.0101
325 HAEMORRHOIDS 161 0.0100
326 RASH PAPULAR 189 0.0100
327 FEELING COLD 228 0.0100
328 DENTAL CARIES 92 0.0100
329 URINARY INCONTINENCE 241 0.0100
330 GASTROINTESTINAL PAIN 83 0.0100
331 MUSCLE ATROPHY 93 0.0100
332 MOBILITY DECREASED 557 0.0100
333 URTICARIA 1267 0.0099
334 RASH MACULAR 263 0.0099
335 FOREIGN BODY SENSATION IN EYES 46 0.0099
336 LABORATORY TEST ABNORMAL 231 0.0099
337 SMALL INTESTINAL OBSTRUCTION 95 0.0099
338 ENERGY INCREASED 50 0.0099
339 SQUAMOUS CELL CARCINOMA 75 0.0099
340 BOWEL MOVEMENT IRREGULARITY 55 0.0099
341 DIVERTICULITIS 216 0.0099
342 CHROMATURIA 185 0.0099
343 SKIN FISSURES 111 0.0099
344 TRICUSPID VALVE INCOMPETENCE 61 0.0098
345 THINKING ABNORMAL 159 0.0098
346 BENIGN PROSTATIC HYPERPLASIA 43 0.0098
347 THERAPY NON-RESPONDER 287 0.0098
348 PLATELET COUNT INCREASED 101 0.0098
349 HEAD INJURY 245 0.0098
350 ARTHROPOD BITE 57 0.0098
351 JOINT DISLOCATION 80 0.0098
352 UPPER GASTROINTESTINAL HAEMORRHAGE 139 0.0097
353 GINGIVAL BLEEDING 100 0.0097
354 CARDIAC PACEMAKER INSERTION 48 0.0097
355 PULMONARY MASS 110 0.0097
356 ANOSMIA 113 0.0097
357 PAIN IN JAW 231 0.0097
358 MEMORY IMPAIRMENT 1076 0.0097
359 PERIPHERAL COLDNESS 108 0.0097
360 PULMONARY THROMBOSIS 82 0.0097
361 RENAL PAIN 82 0.0097
362 RHEUMATOID ARTHRITIS 849 0.0097
363 INFLAMMATION 363 0.0097
364 PARAESTHESIA ORAL 108 0.0096
365 ANORECTAL DISCOMFORT 45 0.0096
366 BONE PAIN 457 0.0096
367 JAW DISORDER 47 0.0096
368 FLANK PAIN 73 0.0096
369 FOOT FRACTURE 151 0.0096
370 CHEST PAIN 1478 0.0096
371 EPISTAXIS 587 0.0096
372 ATRIAL FIBRILLATION 754 0.0096
373 GASTROINTESTINAL DISORDER 567 0.0096
374 STENT PLACEMENT 65 0.0096
375 BLOOD SODIUM DECREASED 145 0.0096
376 RESPIRATORY TRACT CONGESTION 117 0.0095
377 VISION BLURRED 1024 0.0095
378 BLOOD PRESSURE INCREASED 1167 0.0095
379 PAROSMIA 57 0.0095
380 WEIGHT INCREASED 1663 0.0094
381 EAR INFECTION 184 0.0094
382 PRESYNCOPE 180 0.0094
383 DYSSTASIA 228 0.0094
384 URINARY TRACT INFECTION 1237 0.0094
385 FALL 2507 0.0094
386 MACULAR OEDEMA 42 0.0094
387 NASAL DISCOMFORT 62 0.0094
388 DECREASED ACTIVITY 76 0.0094
389 ABNORMAL LOSS OF WEIGHT 51 0.0094
390 DYSPNOEA EXERTIONAL 266 0.0094
391 SKIN DISCOLOURATION 348 0.0093
392 HERNIA 138 0.0093
393 EYE DISCHARGE 68 0.0093
394 INFUSION RELATED REACTION 442 0.0093
395 ORAL DISCOMFORT 106 0.0093
396 VULVOVAGINAL BURNING SENSATION 44 0.0093
397 ARTERIAL OCCLUSIVE DISEASE 62 0.0093
398 ATELECTASIS 76 0.0093
399 KNEE OPERATION 61 0.0093
400 OEDEMA PERIPHERAL 975 0.0093
401 DRUG EFFECT DELAYED 42 0.0092
402 POST PROCEDURAL INFECTION 56 0.0092
403 JOINT INJURY 157 0.0092
404 SKIN WARM 43 0.0092
405 EYE IRRITATION 352 0.0092
406 ORAL DISORDER 55 0.0092
407 CARDIAC MURMUR 70 0.0092
408 CELLULITIS 383 0.0092
409 CHOLECYSTITIS CHRONIC 60 0.0092
410 GALLBLADDER DISORDER 140 0.0092
411 CHILLS 871 0.0092
412 GLAUCOMA 143 0.0092
413 DIARRHOEA 4525 0.0092
414 EXTRASYSTOLES 55 0.0092
415 THYROID DISORDER 111 0.0092
416 DIZZINESS 3661 0.0091
417 IMPAIRED WORK ABILITY 167 0.0091
418 RETINAL DETACHMENT 66 0.0091
419 INCONTINENCE 79 0.0091
420 DYSURIA 278 0.0091
421 INFUSION SITE EXTRAVASATION 46 0.0091
422 GLOMERULAR FILTRATION RATE DECREASED 75 0.0091
423 SKIN DISORDER 232 0.0091
424 QUALITY OF LIFE DECREASED 98 0.0091
425 HEART RATE DECREASED 262 0.0091
426 WHEEZING 391 0.0091
427 BLOOD PRESSURE ABNORMAL 133 0.0091
428 FEELING ABNORMAL 1851 0.0091
429 BLOOD PRESSURE FLUCTUATION 182 0.0091
430 CARDIAC VALVE DISEASE 44 0.0090
431 AMNESIA 496 0.0090
432 TOOTH ABSCESS 78 0.0090
433 INCREASED APPETITE 119 0.0090
434 INFUSION SITE PAIN 77 0.0090
435 MITRAL VALVE INCOMPETENCE 84 0.0090
436 OSTEOPOROSIS 306 0.0090
437 WHITE BLOOD CELL COUNT DECREASED 768 0.0090
438 DEFAECATION URGENCY 41 0.0090
439 OEDEMA 379 0.0090
440 WHITE BLOOD CELL COUNT ABNORMAL 44 0.0090
441 CLOSTRIDIUM DIFFICILE INFECTION 145 0.0090
442 WEIGHT DECREASED 1992 0.0089
443 ARTERIOSCLEROSIS 71 0.0089
444 SOMNAMBULISM 50 0.0089
445 FUNGAL INFECTION 235 0.0089
446 SPLENOMEGALY 85 0.0089
447 TOOTH FRACTURE 81 0.0089
448 PALPITATIONS 836 0.0089
449 UPPER LIMB FRACTURE 152 0.0089
450 WHITE BLOOD CELL COUNT INCREASED 284 0.0089
451 COUGH 1885 0.0088
452 SLUGGISHNESS 73 0.0088
453 MUSCLE TWITCHING 166 0.0088
454 DEPRESSION 1700 0.0088
455 LYMPHOCYTE COUNT DECREASED 124 0.0088
456 BLOOD COUNT ABNORMAL 136 0.0088
457 EYE DISORDER 225 0.0088
458 INJECTION SITE PRURITUS 461 0.0088
459 INTENTIONAL PRODUCT USE ISSUE 546 0.0088
460 ABNORMAL DREAMS 213 0.0087
461 FURUNCLE 57 0.0087
462 PRODUCT LABEL ISSUE 43 0.0087
463 THERAPY CHANGE 53 0.0087
464 FREQUENT BOWEL MOVEMENTS 164 0.0087
465 PRODUCTIVE COUGH 302 0.0087
466 THIRST 124 0.0087
467 MALIGNANT MELANOMA 95 0.0087
468 HEADACHE 4379 0.0087
469 SPINAL DISORDER 67 0.0087
470 ULCER 112 0.0087
471 CHEST DISCOMFORT 690 0.0087
472 INJECTION SITE NODULE 80 0.0086
473 HERPES ZOSTER 399 0.0086
474 INJECTION SITE HAEMATOMA 120 0.0086
475 ACUTE RESPIRATORY FAILURE 124 0.0086
476 ORAL CANDIDIASIS 84 0.0085
477 BREAST PAIN 78 0.0085
478 RASH 2812 0.0085
479 STRESS 474 0.0085
480 SCRATCH 58 0.0085
481 ABDOMINAL DISTENSION 689 0.0085
482 APHONIA 90 0.0085
483 CANDIDA INFECTION 103 0.0085
484 SKIN LESION 177 0.0084
485 THROAT IRRITATION 291 0.0084
486 INJECTION SITE BRUISING 505 0.0084
487 POSTOPERATIVE WOUND INFECTION 44 0.0084
488 DERMATITIS CONTACT 73 0.0084
489 SPINAL FRACTURE 129 0.0084
490 CHOLELITHIASIS 226 0.0084
491 DECREASED APPETITE 1493 0.0084
492 DIPLOPIA 170 0.0084
493 AORTIC ANEURYSM 55 0.0084
494 NEPHROPATHY 67 0.0084
495 HEPATIC STEATOSIS 123 0.0084
496 CHOKING 126 0.0084
497 EYE SWELLING 243 0.0084
498 OCULAR HYPERAEMIA 280 0.0084
499 VERTIGO 418 0.0083
500 IMMUNE SYSTEM DISORDER 85 0.0083
501 HEARING IMPAIRED 50 0.0083
502 HEART RATE INCREASED 655 0.0083
503 SKIN CANCER 141 0.0083
504 RECTAL HAEMORRHAGE 296 0.0083
505 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 263 0.0083
506 INFLUENZA LIKE ILLNESS 582 0.0083
507 LYMPHADENOPATHY 234 0.0083
508 CONFUSIONAL STATE 1095 0.0083
509 HAEMATOCRIT DECREASED 142 0.0083
510 NERVOUSNESS 378 0.0083
511 ERYTHEMA 1359 0.0083
512 STAPHYLOCOCCAL INFECTION 229 0.0082
513 COLD SWEAT 119 0.0082
514 VIRAL INFECTION 204 0.0082
515 GLYCOSYLATED HAEMOGLOBIN INCREASED 158 0.0082
516 PETECHIAE 69 0.0082
517 HYPOPHAGIA 160 0.0082
518 RASH ERYTHEMATOUS 268 0.0082
519 PHARYNGITIS STREPTOCOCCAL 65 0.0082
520 SOMNOLENCE 1316 0.0081
521 PSYCHOLOGICAL TRAUMA 68 0.0081
522 SKIN BURNING SENSATION 476 0.0081
523 PANIC ATTACK 241 0.0081
524 ABASIA 201 0.0081
525 RESPIRATORY TRACT INFECTION 155 0.0081
526 INCORRECT DRUG ADMINISTRATION DURATION 228 0.0081
527 PAIN 4089 0.0081
528 TRANSIENT ISCHAEMIC ATTACK 231 0.0081
529 SPINAL OPERATION 61 0.0081
530 MOTOR DYSFUNCTION 65 0.0081
531 BODY TEMPERATURE DECREASED 68 0.0081
532 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 341 0.0080
533 INSURANCE ISSUE 45 0.0080
534 RETCHING 134 0.0080
535 SKIN INFECTION 67 0.0080
536 LUNG DISORDER 300 0.0080
537 INFUSION SITE ERYTHEMA 42 0.0080
538 MENTAL IMPAIRMENT 158 0.0080
539 EYE PRURITUS 173 0.0080
540 SUPRAVENTRICULAR TACHYCARDIA 63 0.0080
541 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 567 0.0080
542 HYPERHIDROSIS 850 0.0079
543 GASTROINTESTINAL HAEMORRHAGE 588 0.0079
544 URINE OUTPUT DECREASED 59 0.0079
545 PHOTOSENSITIVITY REACTION 105 0.0079
546 ECCHYMOSIS 46 0.0079
547 ORAL HERPES 114 0.0079
548 LIVE BIRTH 44 0.0079
549 KIDNEY INFECTION 122 0.0079
550 HYPERTENSION 1326 0.0079
551 COELIAC DISEASE 59 0.0079
552 PULMONARY CONGESTION 82 0.0079
553 FLUID RETENTION 327 0.0079
554 HIP FRACTURE 199 0.0078
555 INJECTION SITE URTICARIA 138 0.0078
556 ANAL INCONTINENCE 47 0.0078
557 DEPRESSED MOOD 321 0.0078
558 MUSCULOSKELETAL DISORDER 126 0.0078
559 HYPOTHYROIDISM 187 0.0078
560 ANXIETY 1834 0.0078
561 THERMAL BURN 46 0.0077
562 SPINAL COMPRESSION FRACTURE 57 0.0077
563 COGNITIVE DISORDER 284 0.0077
564 MASS 89 0.0077
565 MIGRAINE 555 0.0077
566 IRON DEFICIENCY ANAEMIA 56 0.0077
567 ANGER 223 0.0077
568 SPUTUM DISCOLOURED 56 0.0077
569 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 80 0.0077
570 SECRETION DISCHARGE 67 0.0077
571 INJECTION SITE DISCOLOURATION 74 0.0076
572 DISTURBANCE IN ATTENTION 341 0.0076
573 ELECTROCARDIOGRAM ABNORMAL 51 0.0076
574 GASTROINTESTINAL INFECTION 52 0.0076
575 SENSATION OF FOREIGN BODY 49 0.0076
576 HAEMOGLOBIN DECREASED 641 0.0076
577 WRONG TECHNIQUE IN DRUG USAGE PROCESS 276 0.0076
578 GASTROINTESTINAL INFLAMMATION 44 0.0076
579 BLOOD PRESSURE INADEQUATELY CONTROLLED 42 0.0076
580 HAEMATOCHEZIA 316 0.0076
581 HOSPICE CARE 52 0.0076
582 DRUG EFFECT INCOMPLETE 275 0.0075
583 NAUSEA 4734 0.0075
584 SPINAL PAIN 69 0.0075
585 DEHYDRATION 822 0.0075
586 VISUAL IMPAIRMENT 694 0.0075
587 CHOLECYSTECTOMY 67 0.0075
588 INFECTION 810 0.0075
589 COORDINATION ABNORMAL 92 0.0075
590 BLOOD THYROID STIMULATING HORMONE INCREASED 56 0.0074
591 FULL BLOOD COUNT ABNORMAL 48 0.0074
592 PSORIASIS 779 0.0074
593 SKIN ULCER 156 0.0074
594 INFLUENZA 606 0.0074
595 DRUG DOSE OMISSION 1227 0.0074
596 ECONOMIC PROBLEM 109 0.0074
597 TREMOR 1015 0.0074
598 CLOSTRIDIUM DIFFICILE COLITIS 62 0.0074
599 LETHARGY 349 0.0074
600 EATING DISORDER 128 0.0074
601 INJECTION SITE HAEMORRHAGE 439 0.0073
602 HYPOAESTHESIA ORAL 90 0.0073
603 FRUSTRATION TOLERANCE DECREASED 43 0.0073
604 DRUG INTOLERANCE 529 0.0073
605 DEAFNESS 149 0.0073
606 SUNBURN 46 0.0073
607 INJECTION SITE ERYTHEMA 718 0.0073
608 PULMONARY HYPERTENSION 127 0.0073
609 SCAR 103 0.0073
610 DYSPNOEA 3276 0.0073
611 HYPOKINESIA 87 0.0072
612 APHASIA 179 0.0072
613 THROMBOSIS 475 0.0072
614 RHINITIS 45 0.0071
615 ASTHMA 558 0.0071
616 AFFECTIVE DISORDER 43 0.0071
617 THROAT TIGHTNESS 156 0.0071
618 HYPERSENSITIVITY 1054 0.0071
619 BLINDNESS UNILATERAL 80 0.0071
620 BLOOD GLUCOSE INCREASED 1132 0.0071
621 INTENTIONAL DOSE OMISSION 77 0.0071
622 POOR QUALITY DRUG ADMINISTERED 46 0.0071
623 MOVEMENT DISORDER 187 0.0071
624 SKIN EXFOLIATION 436 0.0071
625 FEAR 171 0.0071
626 INJURY 437 0.0071
627 LIP SWELLING 188 0.0071
628 INTENTIONAL PRODUCT MISUSE 482 0.0070
629 CENTRAL NERVOUS SYSTEM LESION 86 0.0070
630 IMPAIRED QUALITY OF LIFE 65 0.0070
631 APPLICATION SITE PAIN 131 0.0070
632 ERECTILE DYSFUNCTION 141 0.0070
633 RENAL INJURY 195 0.0070
634 FEEDING DISORDER 92 0.0070
635 GASTRIC DISORDER 237 0.0070
636 HAEMORRHAGIC STROKE 46 0.0070
637 ECZEMA 161 0.0070
638 ANGINA UNSTABLE 42 0.0070
639 CORONARY ARTERY DISEASE 194 0.0070
640 SWOLLEN TONGUE 181 0.0069
641 IRRITABILITY 354 0.0069
642 RASH GENERALISED 180 0.0069
643 CONDITION AGGRAVATED 1505 0.0069
644 DRUG ADMINISTERED AT INAPPROPRIATE SITE 73 0.0069
645 GASTRITIS 149 0.0069
646 LIBIDO DECREASED 71 0.0069
647 MOOD ALTERED 151 0.0069
648 RENAL FAILURE CHRONIC 53 0.0069
649 DISABILITY 108 0.0069
650 BLOOD PRESSURE DECREASED 367 0.0069
651 EYELID OEDEMA 72 0.0069
652 PLATELET COUNT DECREASED 578 0.0069
653 IMMUNODEFICIENCY 68 0.0069
654 PERSONALITY CHANGE 56 0.0069
655 DRY SKIN 653 0.0068
656 LIVER FUNCTION TEST INCREASED 99 0.0068
657 NIGHTMARE 198 0.0068
658 RED BLOOD CELL SEDIMENTATION RATE INCREASED 60 0.0068
659 EYELID PTOSIS 53 0.0068
660 PULMONARY FIBROSIS 96 0.0068
661 PNEUMONIA 1699 0.0068
662 SPEECH DISORDER 293 0.0068
663 DRUG EFFECT DECREASED 366 0.0068
664 COAGULOPATHY 95 0.0068
665 VISUAL FIELD DEFECT 42 0.0068
666 SENSORY LOSS 45 0.0068
667 HALLUCINATION 385 0.0068
668 INJECTION SITE PAIN 1475 0.0067
669 RENAL FAILURE 785 0.0067
670 MULTIPLE SCLEROSIS 267 0.0067
671 APATHY 78 0.0067
672 POST PROCEDURAL COMPLICATION 107 0.0067
673 EXPIRED PRODUCT ADMINISTERED 175 0.0067
674 INJECTION SITE RASH 148 0.0067
675 SUBDURAL HAEMATOMA 81 0.0066
676 CONJUNCTIVITIS 85 0.0066
677 BLOOD CALCIUM DECREASED 62 0.0066
678 VISUAL ACUITY REDUCED 203 0.0066
679 OESOPHAGITIS 58 0.0066
680 MULTIPLE SCLEROSIS RELAPSE 403 0.0066
681 INJECTION SITE REACTION 363 0.0066
682 PROCEDURAL PAIN 138 0.0066
683 HYPOACUSIS 209 0.0066
684 DYSPHAGIA 482 0.0065
685 UNEVALUABLE EVENT 423 0.0065
686 INJECTION SITE MASS 182 0.0065
687 INJECTION SITE INDURATION 72 0.0065
688 INJECTION SITE EXTRAVASATION 76 0.0065
689 DEEP VEIN THROMBOSIS 372 0.0065
690 ABDOMINAL PAIN 1204 0.0065
691 WITHDRAWAL SYNDROME 206 0.0065
692 GASTRIC ULCER 103 0.0065
693 BLOOD UREA INCREASED 94 0.0065
694 PRODUCT USE ISSUE 904 0.0065
695 CARDIAC FAILURE CONGESTIVE 477 0.0065
696 MOOD SWINGS 176 0.0064
697 URINARY RETENTION 170 0.0064
698 PRODUCT DOSE OMISSION 427 0.0064
699 ANHEDONIA 156 0.0064
700 INJECTION SITE WARMTH 114 0.0064
701 DYSKINESIA 213 0.0064
702 MENTAL STATUS CHANGES 147 0.0064
703 DERMATITIS ATOPIC 88 0.0064
704 SWELLING FACE 334 0.0064
705 ADVERSE DRUG REACTION 401 0.0064
706 PAIN OF SKIN 141 0.0064
707 HAEMATOMA 141 0.0064
708 ACUTE KIDNEY INJURY 729 0.0064
709 HAEMATURIA 185 0.0064
710 HEMIPARESIS 92 0.0064
711 EMPHYSEMA 54 0.0063
712 AFFECT LABILITY 53 0.0063
713 CRYING 200 0.0063
714 ACCIDENT 58 0.0063
715 INJECTION SITE SWELLING 359 0.0063
716 BLOOD PRESSURE SYSTOLIC INCREASED 97 0.0063
717 ANGINA PECTORIS 157 0.0063
718 ANAEMIA 981 0.0063
719 POST PROCEDURAL HAEMORRHAGE 62 0.0063
720 INJECTION SITE DISCOMFORT 45 0.0063
721 DERMATITIS 93 0.0063
722 CROHN'S DISEASE 43 0.0063
723 OBSESSIVE-COMPULSIVE DISORDER 44 0.0063
724 CARDIOMEGALY 69 0.0063
725 VOMITING 2297 0.0062
726 OSTEOMYELITIS 96 0.0062
727 PARANOIA 90 0.0062
728 INTERNATIONAL NORMALISED RATIO INCREASED 167 0.0062
729 BREAST TENDERNESS 42 0.0062
730 BLOOD GLUCOSE DECREASED 253 0.0062
731 BLOOD TEST ABNORMAL 65 0.0062
732 DYSARTHRIA 191 0.0062
733 SINUS BRADYCARDIA 49 0.0062
734 PHARYNGEAL OEDEMA 93 0.0061
735 PRODUCT DOSE OMISSION IN ERROR 52 0.0061
736 DIARRHOEA HAEMORRHAGIC 46 0.0061
737 DIABETES MELLITUS 392 0.0061
738 RENAL DISORDER 229 0.0061
739 PANCREATITIS 263 0.0061
740 EMOTIONAL DISORDER 157 0.0061
741 SURGERY 245 0.0060
742 UROSEPSIS 44 0.0060
743 APPLICATION SITE RASH 74 0.0060
744 INCORRECT DOSE ADMINISTERED 885 0.0060
745 UNDERDOSE 346 0.0060
746 BEDRIDDEN 64 0.0060
747 PLASMA CELL MYELOMA 182 0.0060
748 PYREXIA 1648 0.0059
749 OVARIAN CYST 51 0.0059
750 FEMUR FRACTURE 157 0.0059
751 MALAISE 2129 0.0059
752 PSYCHOMOTOR HYPERACTIVITY 84 0.0058
753 BLOOD GLUCOSE FLUCTUATION 54 0.0058
754 MOUTH ULCERATION 94 0.0058
755 RESTLESSNESS 177 0.0058
756 DISORIENTATION 197 0.0058
757 TOOTH EXTRACTION 60 0.0058
758 ATAXIA 58 0.0058
759 TREATMENT FAILURE 343 0.0058
760 ELECTROLYTE IMBALANCE 51 0.0058
761 DISEASE RECURRENCE 182 0.0057
762 PRODUCT ODOUR ABNORMAL 43 0.0057
763 SYNCOPE 471 0.0057
764 SARS-COV-2 TEST POSITIVE 59 0.0057
765 PRODUCT QUALITY ISSUE 684 0.0057
766 BLOOD CREATININE INCREASED 305 0.0057
767 RENAL TUBULAR NECROSIS 44 0.0057
768 COMA 221 0.0056
769 DELUSION 68 0.0056
770 COVID-19 649 0.0056
771 DRUG HYPERSENSITIVITY 903 0.0056
772 HYPERCALCAEMIA 55 0.0056
773 PARALYSIS 66 0.0056
774 LEUKOCYTOSIS 80 0.0056
775 BIPOLAR DISORDER 52 0.0055
776 TUBULOINTERSTITIAL NEPHRITIS 81 0.0055
777 PREGNANCY 100 0.0055
778 INTRAOCULAR PRESSURE INCREASED 59 0.0055
779 INTENTIONAL DRUG MISUSE 115 0.0055
780 ORTHOSTATIC HYPOTENSION 78 0.0055
781 HYPOXIA 149 0.0055
782 DEFORMITY 45 0.0054
783 PULMONARY EMBOLISM 442 0.0054
784 HAEMORRHAGE 445 0.0054
785 PRODUCT TASTE ABNORMAL 57 0.0054
786 DEMENTIA 111 0.0054
787 APPLICATION SITE ERYTHEMA 127 0.0054
788 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 101 0.0054
789 DRUG LEVEL DECREASED 41 0.0054
790 SUICIDAL IDEATION 403 0.0054
791 PHARYNGITIS 55 0.0054
792 THERAPEUTIC RESPONSE DECREASED 247 0.0054
793 BLOOD GLUCOSE ABNORMAL 80 0.0054
794 APPLICATION SITE IRRITATION 56 0.0053
795 COVID-19 PNEUMONIA 45 0.0053
796 ILLNESS 238 0.0053
797 PRODUCT DOSE OMISSION ISSUE 702 0.0053
798 LOSS OF CONSCIOUSNESS 557 0.0053
799 THERAPY INTERRUPTED 154 0.0053
800 EXTRA DOSE ADMINISTERED 119 0.0053
801 DEVICE MALFUNCTION 247 0.0053
802 HAEMOPTYSIS 122 0.0053
803 LIVER FUNCTION TEST ABNORMAL 137 0.0053
804 HYPERTHYROIDISM 58 0.0053
805 CARDIAC DISORDER 409 0.0052
806 LUNG INFILTRATION 42 0.0052
807 HYPOTENSION 842 0.0052
808 PELVIC PAIN 78 0.0052
809 RENAL FAILURE ACUTE 222 0.0052
810 OXYGEN SATURATION DECREASED 214 0.0052
811 ADVERSE REACTION 55 0.0052
812 LUNG INFECTION 81 0.0052
813 SKIN REACTION 57 0.0052
814 PLEURAL EFFUSION 255 0.0051
815 INJECTION SITE IRRITATION 52 0.0051
816 ABSCESS 64 0.0051
817 RESPIRATORY DEPRESSION 52 0.0051
818 INCORRECT PRODUCT ADMINISTRATION DURATION 73 0.0051
819 DRUG ADMINISTRATION ERROR 156 0.0051
820 MANIA 69 0.0051
821 ASPIRATION 42 0.0050
822 CARDIOMYOPATHY 62 0.0050
823 NO THERAPEUTIC RESPONSE 61 0.0050
824 PANCREATITIS ACUTE 87 0.0050
825 APPLICATION SITE PRURITUS 97 0.0050
826 RENAL IMPAIRMENT 322 0.0050
827 HYPOTONIA 42 0.0050
828 LIVER DISORDER 171 0.0049
829 PRODUCT AVAILABILITY ISSUE 51 0.0049
830 PERICARDIAL EFFUSION 88 0.0049
831 AGITATION 306 0.0049
832 DRUG INEFFECTIVE 5051 0.0049
833 COLITIS 132 0.0048
834 ACUTE MYOCARDIAL INFARCTION 123 0.0048
835 DEVICE OCCLUSION 42 0.0048
836 SEXUAL DYSFUNCTION 44 0.0048
837 DEVICE RELATED INFECTION 63 0.0048
838 MELAENA 89 0.0048
839 SEPSIS 430 0.0048
840 UNRESPONSIVE TO STIMULI 99 0.0048
841 LYMPHOMA 61 0.0048
842 PRODUCT PRESCRIBING ERROR 74 0.0048
843 PULMONARY OEDEMA 174 0.0048
844 MULTIPLE FRACTURES 69 0.0047
845 CHOLECYSTITIS 45 0.0047
846 ARRHYTHMIA 189 0.0047
847 DERMATITIS ALLERGIC 43 0.0047
848 MATERNAL EXPOSURE DURING PREGNANCY 286 0.0047
849 CEREBRAL HAEMORRHAGE 138 0.0047
850 GENERAL PHYSICAL HEALTH DETERIORATION 387 0.0046
851 TREATMENT NONCOMPLIANCE 182 0.0046
852 INTESTINAL OBSTRUCTION 130 0.0046
853 ALANINE AMINOTRANSFERASE INCREASED 236 0.0046
854 THERAPEUTIC RESPONSE SHORTENED 69 0.0046
855 GASTRIC HAEMORRHAGE 47 0.0046
856 COLON CANCER 56 0.0046
857 GENERALISED OEDEMA 44 0.0046
858 BACTERIAL INFECTION 64 0.0046
859 INTERNAL HAEMORRHAGE 43 0.0046
860 DYSMENORRHOEA 48 0.0046
861 COLITIS ULCERATIVE 133 0.0046
862 PRODUCT PHYSICAL ISSUE 66 0.0045
863 OFF LABEL USE 2519 0.0045
864 ABNORMAL BEHAVIOUR 158 0.0045
865 HALLUCINATION, VISUAL 71 0.0045
866 SEIZURE 369 0.0044
867 ABDOMINAL PAIN LOWER 93 0.0044
868 CEREBROVASCULAR ACCIDENT 641 0.0044
869 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 171 0.0044
870 PALLOR 101 0.0044
871 PRODUCT USE IN UNAPPROVED INDICATION 689 0.0044
872 ADVERSE EVENT 322 0.0043
873 MENTAL DISORDER 152 0.0043
874 ASPARTATE AMINOTRANSFERASE INCREASED 189 0.0043
875 NEUTROPHIL COUNT DECREASED 128 0.0043
876 METASTASES TO LIVER 58 0.0043
877 ACNE 278 0.0043
878 HAEMORRHAGE INTRACRANIAL 56 0.0043
879 MYOCARDIAL INFARCTION 669 0.0042
880 SKIN IRRITATION 164 0.0042
881 BLINDNESS 132 0.0042
882 DEVICE ISSUE 250 0.0042
883 DRUG DISPENSING ERROR 64 0.0042
884 INCORRECT PRODUCT STORAGE 55 0.0042
885 FLUID OVERLOAD 61 0.0042
886 VAGINAL HAEMORRHAGE 155 0.0042
887 DRUG PRESCRIBING ERROR 80 0.0042
888 GASTROENTERITIS 48 0.0041
889 EJECTION FRACTION DECREASED 51 0.0041
890 DISEASE PROGRESSION 356 0.0041
891 VENTRICULAR TACHYCARDIA 54 0.0041
892 DIABETES MELLITUS INADEQUATE CONTROL 59 0.0041
893 FRACTURE 63 0.0041
894 METASTASES TO BONE 48 0.0041
895 MEDICATION ERROR 182 0.0040
896 DELIRIUM 106 0.0040
897 SEDATION 78 0.0040
898 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 186 0.0040
899 AGGRESSION 169 0.0040
900 BONE LOSS 52 0.0039
901 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0039
902 NEOPLASM PROGRESSION 109 0.0039
903 NEEDLE ISSUE 69 0.0039
904 BONE DENSITY DECREASED 108 0.0038
905 HEPATIC CIRRHOSIS 54 0.0038
906 BRADYCARDIA 169 0.0038
907 DEVICE FAILURE 43 0.0038
908 PNEUMONITIS 73 0.0037
909 DRUG INTERACTION 477 0.0037
910 HAEMATEMESIS 78 0.0037
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 366 0.0037
912 HALLUCINATION, AUDITORY 46 0.0036
913 PNEUMOTHORAX 45 0.0036
914 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 523 0.0036
915 SINUS TACHYCARDIA 42 0.0036
916 PRODUCT ADMINISTRATION ERROR 45 0.0036
917 DIALYSIS 43 0.0036
918 PROTEINURIA 50 0.0036
919 PANCYTOPENIA 152 0.0035
920 EXPOSURE DURING PREGNANCY 165 0.0035
921 PULMONARY ARTERIAL HYPERTENSION 43 0.0035
922 RESPIRATORY FAILURE 207 0.0035
923 TOOTH LOSS 60 0.0034
924 TACHYCARDIA 232 0.0033
925 MENORRHAGIA 64 0.0033
926 BLOOD BILIRUBIN INCREASED 73 0.0032
927 ENCEPHALOPATHY 60 0.0032
928 INCORRECT DOSE ADMINISTERED BY DEVICE 42 0.0032
929 HOSPITALISATION 336 0.0031
930 HYPONATRAEMIA 144 0.0031
931 HYPOKALAEMIA 112 0.0031
932 CONVULSION 175 0.0031
933 NERVOUS SYSTEM DISORDER 83 0.0031
934 PSYCHOTIC DISORDER 74 0.0031
935 ISCHAEMIC STROKE 45 0.0031
936 NEOPLASM MALIGNANT 153 0.0030
937 HYPERGLYCAEMIA 86 0.0029
938 EMOTIONAL DISTRESS 321 0.0029
939 RHABDOMYOLYSIS 96 0.0028
940 PRODUCT ADHESION ISSUE 74 0.0028
941 FEBRILE NEUTROPENIA 139 0.0028
942 ACCIDENTAL OVERDOSE 76 0.0028
943 ASCITES 66 0.0028
944 DEVICE LEAKAGE 59 0.0027
945 CARDIAC ARREST 188 0.0027
946 MALIGNANT NEOPLASM PROGRESSION 204 0.0027
947 OSTEONECROSIS OF JAW 59 0.0027
948 CARDIAC FAILURE 173 0.0027
949 HYPOGLYCAEMIA 108 0.0027
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 56 0.0027
951 SEPTIC SHOCK 87 0.0026
952 THROMBOCYTOPENIA 227 0.0026
953 HYPERKALAEMIA 72 0.0026
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 65 0.0026
955 DIABETIC KETOACIDOSIS 48 0.0025
956 RASH MACULO-PAPULAR 42 0.0025
957 DRUG-INDUCED LIVER INJURY 48 0.0025
958 TARDIVE DYSKINESIA 63 0.0024
959 ANAPHYLACTIC REACTION 97 0.0024
960 ANGIOEDEMA 83 0.0024
961 RESPIRATORY DISTRESS 54 0.0024
962 NEUTROPENIA 237 0.0024
963 DEVICE BREAKAGE 51 0.0023
964 LUNG NEOPLASM MALIGNANT 83 0.0023
965 INCORRECT ROUTE OF DRUG ADMINISTRATION 80 0.0022
966 DEPRESSED LEVEL OF CONSCIOUSNESS 72 0.0022
967 DRUG WITHDRAWAL SYNDROME 186 0.0022
968 DEVICE DISLOCATION 77 0.0022
969 NO ADVERSE EVENT 252 0.0022
970 ACCIDENTAL EXPOSURE TO PRODUCT 119 0.0021
971 HEPATITIS 43 0.0021
972 LEUKOPENIA 82 0.0021
973 DEATH 1394 0.0021
974 ABORTION SPONTANEOUS 67 0.0020
975 PRODUCT STORAGE ERROR 87 0.0020
976 BREAST CANCER 169 0.0020
977 RESPIRATORY ARREST 48 0.0019
978 MENSTRUATION IRREGULAR 46 0.0019
979 C-REACTIVE PROTEIN INCREASED 53 0.0019
980 HEPATIC FAILURE 48 0.0019
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 49 0.0018
982 ELECTROCARDIOGRAM QT PROLONGED 49 0.0017
983 CARDIO-RESPIRATORY ARREST 61 0.0017
984 SUICIDE ATTEMPT 82 0.0017
985 OVERDOSE 289 0.0017
986 OSTEONECROSIS 46 0.0016
987 INTERSTITIAL LUNG DISEASE 55 0.0015
988 PROSTATE CANCER 113 0.0015
989 DEVICE EXPULSION 74 0.0013
990 RENAL CANCER 48 0.0010
991 TOXICITY TO VARIOUS AGENTS 133 0.0010
992 BLADDER CANCER 57 0.0010
993 DRUG ABUSE 66 0.0010
994 DRUG DEPENDENCE 127 0.0008
995 COMPLETED SUICIDE 51 0.0007